{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "22438325",
  "DateCompleted": {
    "Year": "2012",
    "Month": "05",
    "Day": "31"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2012",
        "Month": "03",
        "Day": "20"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1093/infdis/jis209"
    ],
    "Journal": {
      "ISSN": "1537-6613",
      "JournalIssue": {
        "Volume": "205",
        "Issue": "9",
        "PubDate": {
          "Year": "2012",
          "Month": "May",
          "Day": "01"
        }
      },
      "Title": "The Journal of infectious diseases",
      "ISOAbbreviation": "J Infect Dis"
    },
    "ArticleTitle": "Transmission of GB virus type C via transfusion in a cohort of HIV-infected patients.",
    "Pagination": {
      "StartPage": "1436",
      "EndPage": "1442",
      "MedlinePgn": "1436-42"
    },
    "Abstract": {
      "AbstractText": [
        "GB virus C (GBV-C) infection is transmitted by blood exposure and associated with lower human immunodeficiency virus (HIV) load and slower HIV disease progression. Few studies describe predictors of acute GBV-C infection following transfusion in HIV-infected patients.",
        "We used a limited-access database from the National Heart Lung and Blood Institute's Viral Activation Transfusion Study, a randomized controlled trial of leukoreduced versus nonleukoreduced transfusions received by HIV-infected, transfusion-naive patients. Blood samples from 489 subjects were tested for GBV-C markers in pretransfusion and posttransfusion samples. We estimated the risk of acquiring GBV-C RNA and predictors of GBV-C acquisition, using pooled logistic regression.",
        "GBV-C RNA was detected \u2264120 days following the first transfusion in 22 (7.5%) of 294 subjects who were GBV-C negative before transfusion. The risk of GBV-C RNA acquisition increased with each unit transfused (odds ratio, 1.09; 95% confidence interval, 1.06-1.11). Lower baseline HIV load and use of antiretroviral therapy were associated with subsequent GBV-C RNA acquisition, after control for units of blood transfused. Leukoreduced status of transfused units was not associated with GBV-C transmission.",
        "Blood transfusion is associated with a significant risk of GBV-C acquisition among HIV-infected patients. Transmission of GBV-C by blood transfusion was inversely related to HIV load."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Epidemiology, Blood Systems Research Institute, San Francisco, CA, USA. FVahidnia@bloodsystems.org"
          }
        ],
        "LastName": "Vahidnia",
        "ForeName": "Farnaz",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Petersen",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rutherford",
        "ForeName": "G",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Busch",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Assmann",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Stapleton",
        "ForeName": "J T",
        "Initials": "JT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Custer",
        "ForeName": "B",
        "Initials": "B"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 AI058740",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI 058740",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Multicenter Study",
      "Randomized Controlled Trial",
      "Research Support, N.I.H., Extramural",
      "Research Support, U.S. Gov't, Non-P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Infect Dis",
    "NlmUniqueID": "0413675",
    "ISSNLinking": "0022-1899"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Viral"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "CD4 Lymphocyte Count"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "complications",
        "transmission",
        "virology"
      ],
      "DescriptorName": "Flaviviridae Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Follow-Up Studies"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "pathogenicity"
      ],
      "DescriptorName": "GB virus C"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "pathogenicity"
      ],
      "DescriptorName": "HIV"
    },
    {
      "QualifierName": [
        "complications",
        "transmission",
        "virology"
      ],
      "DescriptorName": "HIV Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Logistic Models"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prospective Studies"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "RNA, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Transfusion Reaction"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Viral Load"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virus Activation"
    }
  ]
}